Melior Pharmaceuticals Announces Positive Results in Phase 2B Study with Tolimidone for Type 2 Diabetes
• Tolimidone treatment significantly reduced HbA1c compared to placebo
• Company makes strategic decision to move tolimidone into NASH development

See more here